-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
المؤلفون: Shiota H; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Alekseyenko AA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Genetics, Harvard Medical School, Boston, Massachusetts., Wang ZA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Filic I; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Knox TM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Luong NM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Huang Y; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Scott DA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Jones KL; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Gokhale PC; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Lemieux ME; Bioinfo, Plantagenet, Ontario, Canada., Cole PA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Kuroda MI; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Genetics, Harvard Medical School, Boston, Massachusetts., French CA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. cfrench@bwh.harvard.edu.
المصدر: Molecular cancer research : MCR [Mol Cancer Res] 2021 Nov; Vol. 19 (11), pp. 1818-1830. Date of Electronic Publication: 2021 Jul 20.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Squamous Cell/*drug therapy , Carcinoma, Squamous Cell/*genetics , Cell Cycle Proteins/*genetics , Early Detection of Cancer/*methods , High-Throughput Nucleotide Sequencing/*methods , Histone Deacetylase Inhibitors/*therapeutic use , Nuclear Proteins/*genetics , Transcription Factors/*genetics, Animals ; Cell Line, Tumor ; Female ; Histone Deacetylase Inhibitors/pharmacology ; Humans ; Male ; Mice
-
7دورية أكاديمية
المؤلفون: Morrison-Smith CD; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Knox TM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Filic I; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Soroko KM; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Eschle BK; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Wilkens MK; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Gokhale PC; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Giles F; Developmental Therapeutics Consortium, Chicago, Ilinois., Griffin A; Praxis Precision Medicines, Cambridge, Massachusetts., Brown B; Paraza Pharma Inc., Montreal, Quebec, Canada., Shapiro GI; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Zucconi BE; Department of Medicine, Division of Genetics, Brigham and Women's Hospital and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Cole PA; Department of Medicine, Division of Genetics, Brigham and Women's Hospital and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Lemieux ME; Bioinfo, Plantagenet, Ontario, Canada., French CA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. cfrench@bwh.harvard.edu.
المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Jul; Vol. 19 (7), pp. 1406-1414. Date of Electronic Publication: 2020 May 05.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Benzimidazoles/*pharmacology , Carcinoma/*drug therapy , Cell Cycle Proteins/*antagonists & inhibitors , E1A-Associated p300 Protein/*antagonists & inhibitors , Gene Expression Regulation, Neoplastic/*drug effects , Neoplasm Proteins/*antagonists & inhibitors , Nuclear Proteins/*antagonists & inhibitors , Pyridones/*pharmacology , Transcription Factors/*antagonists & inhibitors, Animals ; Apoptosis ; Biomarkers, Tumor ; Carcinoma/metabolism ; Carcinoma/pathology ; Cell Cycle ; Cell Proliferation ; Humans ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
-
8دورية أكاديمية
المؤلفون: Ferris CF; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States.; Depts Psychology and Pharmaceutical Sciences, Northeastern University, United States., Nodine S; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Pottala T; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Cai X; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Knox TM; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Fofana FH; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Kim S; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Kulkarni P; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Crystal JD; Dept of Psychology and Brain Sciences, Indiana University, Bloomington, IN, United States., Hohmann AG; Dept of Psychology and Brain Sciences, Indiana University, Bloomington, IN, United States.
المصدر: Neurobiology of pain (Cambridge, Mass.) [Neurobiol Pain] 2019 May 27; Vol. 6, pp. 100034. Date of Electronic Publication: 2019 May 27 (Print Publication: 2019).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 101705141 Publication Model: eCollection Cited Medium: Print ISSN: 2452-073X (Print) Linking ISSN: 2452073X NLM ISO Abbreviation: Neurobiol Pain Subsets: PubMed not MEDLINE